Feeds › Planned insider sales
Planned insider sales
Notices (SEC Form 144) that executives and other insiders file before selling shares, and whether a sale was reported afterwards.
About this data
- What it is
- Before an executive, director or large owner sells restricted or control shares, they file a short notice with the SEC, called Form 144, saying how many shares they plan to sell, through which broker and roughly when. This feed lists those notices, and for each one shows whether a sale was reported afterwards on a Form 4 and how many days later.
- Who files it
- The person selling, or their broker, on the day the sale is placed. Electronic notices start in April 2023.
- How current
- We collect new notices throughout the day on SEC business days.
- Terms
- Form 144The notice an insider or other affiliate of a company files with the SEC before selling restricted or control shares, so the shares can be sold under Rule 144. The notice says how many shares, through which broker, and roughly when.10b5-1 planA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan.
- Worth knowing
- A notice is a plan, not a sale: the person may sell fewer shares, later, or not at all. The value is the one the filer typed, at a price they chose, not what the shares sell for. Many sales are routine, made to diversify or pay taxes, or under a 10b5-1 plan set up months earlier. A blank in the last column does not mean no sale: the person may not have to file a Form 4 (an ordinary affiliate does not), the sale may be recent, or the Form 4 may name a different spelling of the person. We match by the filer's number first and by name second. Information, not investment advice.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Form 144 notices per day, last 30 days
All notices Notices that give a 10b5-1 plan
By the day each notice was filed. A notice is a plan to sell, not a sale.
Latest notices of planned insider sales
Showing: ticker VYGR
| Filed | Insider | Company | Shares to sellA notice is a plan, not a sale. The person may sell fewer shares, sell later, or not sell at all, and the number of shares is what they expect to sell on the day they file. | ValueThe aggregate market value the filer typed on the notice: the shares times a price the filer chose. It is not what the shares will sell for. | PlanA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan. | Expected sale | Sale reportedInsiders who are officers, directors or hold more than 10% report their sales on a Form 4, within two business days. We look for the first Form 4 with an open-market sale by the same person in the same company within 90 days of the notice, and show how many days after the notice it was filed. A blank means we found none: the person may not have sold, may not have to file a Form 4, or the Form 4 may be one we do not have. | Notice |
|---|---|---|---|---|---|---|---|---|
| May 15, 2026 | Nathan D. Jorgensen Former Officer | VYGR Voyager Therapeutics, Inc. | 25,000 | $96.9K | — | May 15, 2026 | — | Form 144 ↗ |
| May 15, 2026 | Nathan D. Jorgensen Former Officer | VYGR Voyager Therapeutics, Inc. | 9,406 | $39.9K | — | May 15, 2026 | — | Form 144 ↗ |
| Apr 2, 2026 | Alfred Sandrock Officer, Director | VYGR Voyager Therapeutics, Inc. | 11,511 | $44.6K | — | Apr 2, 2026 | Form 4 ↗ 1 day later · 11,511 shares | Form 144 ↗ |
| Feb 24, 2026 | Todd Alfred Carter Officer | VYGR Voyager Therapeutics, Inc. | 4,174 | $15.7K | — | Feb 24, 2026 | Form 4 ↗ 2 days later · 4,174 shares | Form 144 ↗ |
| Feb 24, 2026 | Nathan D. Jorgensen Officer | VYGR Voyager Therapeutics, Inc. | 4,668 | $17.6K | — | Feb 24, 2026 | Form 4 ↗ 2 days later · 4,668 shares | Form 144 ↗ |
| Feb 24, 2026 | Swartz Robin Officer | VYGR Voyager Therapeutics, Inc. | 6,458 | $24.3K | — | Feb 24, 2026 | Form 4 ↗ 2 days later · 6,458 shares | Form 144 ↗ |
| Feb 24, 2026 | Alfred Sandrock Officer, Director | VYGR Voyager Therapeutics, Inc. | 14,197 | $53.9K | — | Feb 24, 2026 | Form 4 ↗ 2 days later · 14,197 shares | Form 144 ↗ |
| Feb 18, 2026 | Alfred Sandrock Officer, Director | VYGR Voyager Therapeutics, Inc. | 11,732 | $40.0K | — | Feb 18, 2026 | Form 4 ↗ 2 days later · 11,732 shares | Form 144 ↗ |
| Feb 18, 2026 | Todd Alfred Carter Officer | VYGR Voyager Therapeutics, Inc. | 3,301 | $11.3K | — | Feb 18, 2026 | Form 4 ↗ 2 days later · 3,301 shares | Form 144 ↗ |
| Feb 18, 2026 | Swartz Robin Officer | VYGR Voyager Therapeutics, Inc. | 3,882 | $13.3K | — | Feb 18, 2026 | Form 4 ↗ 2 days later · 3,882 shares | Form 144 ↗ |
| Feb 10, 2026 | Alfred Sandrock Officer, Director | VYGR Voyager Therapeutics, Inc. | 12,192 | $46.1K | — | Feb 10, 2026 | Form 4 ↗ 1 day later · 12,192 shares | Form 144 ↗ |
| Feb 10, 2026 | Swartz Robin Officer | VYGR Voyager Therapeutics, Inc. | 4,569 | $17.6K | — | Feb 10, 2026 | Form 4 ↗ 1 day later · 4,569 shares | Form 144 ↗ |
| Feb 10, 2026 | Todd Alfred Carter Officer | VYGR Voyager Therapeutics, Inc. | 3,525 | $13.6K | — | Feb 10, 2026 | Form 4 ↗ 1 day later · 3,525 shares | Form 144 ↗ |
| Oct 3, 2025 | Fahey Sandell Jacquelyn Officer | VYGR Voyager Therapeutics, Inc. | 5,843 | $27.9K | — | Oct 3, 2025 | — | Form 144 ↗ |
| Oct 3, 2025 | Nathan D. Jorgensen Officer | VYGR Voyager Therapeutics, Inc. | 7,666 | $36.6K | — | Oct 3, 2025 | Form 4 ↗ 4 days later · 7,666 shares | Form 144 ↗ |
| Aug 18, 2025 | Toby Ferguson Officer | VYGR Voyager Therapeutics, Inc. | 19,000 | $70.7K | — | Aug 18, 2025 | Form 4 ↗ 2 days later · 19,000 shares | Form 144 ↗ |
| Apr 2, 2025 | Alfred Sandrock Officer, Director | VYGR Voyager Therapeutics, Inc. | 10,885 | $37.4K | — | Apr 2, 2025 | Form 4 ↗ 2 days later · 10,885 shares | Form 144 ↗ |
| Apr 2, 2025 | Toby Ferguson Officer | VYGR Voyager Therapeutics, Inc. | 10,086 | $34.6K | — | Apr 2, 2025 | Form 4 ↗ 2 days later · 10,086 shares | Form 144 ↗ |
| Feb 20, 2025 | Alfred Sandrock Officer, Director | VYGR Voyager Therapeutics, Inc. | 11,702 | $49.7K | — | Feb 20, 2025 | Form 4 ↗ 4 days later · 11,702 shares | Form 144 ↗ |
| Feb 20, 2025 | Todd Alfred Carter Officer | VYGR Voyager Therapeutics, Inc. | 3,305 | $14.1K | — | Feb 20, 2025 | Form 4 ↗ 4 days later · 3,305 shares | Form 144 ↗ |
| Feb 20, 2025 | Swartz Robin Officer | VYGR Voyager Therapeutics, Inc. | 3,894 | $16.6K | — | Feb 20, 2025 | Form 4 ↗ 4 days later · 3,894 shares | Form 144 ↗ |
| Feb 11, 2025 | Fahey Sandell Jacquelyn Officer | VYGR Voyager Therapeutics, Inc. | 4,358 | $19.4K | — | Feb 11, 2025 | Form 4 ↗ 1 day later · 4,358 shares | Form 144 ↗ |
| Feb 11, 2025 | Todd Alfred Carter Officer | VYGR Voyager Therapeutics, Inc. | 5,413 | $24.1K | — | Feb 11, 2025 | Form 4 ↗ 1 day later · 5,413 shares | Form 144 ↗ |
| Feb 11, 2025 | Alfred Sandrock Officer, Director | VYGR Voyager Therapeutics, Inc. | 16,644 | $74.0K | — | Feb 11, 2025 | Form 4 ↗ 1 day later · 16,644 shares | Form 144 ↗ |
| Feb 11, 2025 | Swartz Robin Officer | VYGR Voyager Therapeutics, Inc. | 6,950 | $30.9K | — | Feb 11, 2025 | Form 4 ↗ 1 day later · 6,950 shares | Form 144 ↗ |
| Jan 14, 2025 | Swartz Robin Officer | VYGR Voyager Therapeutics, Inc. | 3,087 | $15.7K | — | Jan 14, 2025 | Form 4 ↗ 1 day later · 3,087 shares | Form 144 ↗ |
| Jan 14, 2025 | Todd Alfred Carter Officer | VYGR Voyager Therapeutics, Inc. | 1,191 | $6,106 | — | Jan 14, 2025 | Form 4 ↗ 1 day later · 1,191 shares | Form 144 ↗ |
| Dec 23, 2024 | Swartz Robin Officer | VYGR Voyager Therapeutics, Inc. | 6,500 | $36.7K | — | Dec 23, 2024 | Form 4 ↗ 3 days later · 6,500 shares | Form 144 ↗ |
| Oct 2, 2024 | Fahey Sandell Jacquelyn Officer | VYGR Voyager Therapeutics, Inc. | 5,999 | $34.9K | — | Oct 2, 2024 | Form 4 ↗ 1 day later · 5,999 shares | Form 144 ↗ |
| Apr 2, 2024 | Swartz Robin Officer | VYGR Voyager Therapeutics, Inc. | 1,357 | $13.4K | — | Apr 2, 2024 | — | Form 144 ↗ |
| Apr 2, 2024 | Alfred Sandrock Officer, Director | VYGR Voyager Therapeutics, Inc. | 12,115 | $119.5K | — | Apr 2, 2024 | — | Form 144 ↗ |
| Feb 21, 2024 | Alfred Sandrock Officer, Director | VYGR Voyager Therapeutics, Inc. | 13,033 | $97.2K | — | Feb 21, 2024 | — | Form 144 ↗ |
| Feb 21, 2024 | Peter P. Pfreundschuh Officer | VYGR Voyager Therapeutics, Inc. | 3,764 | $28.1K | — | Feb 21, 2024 | — | Form 144 ↗ |
| Feb 21, 2024 | Swartz Robin Officer | VYGR Voyager Therapeutics, Inc. | 3,966 | $29.6K | — | Feb 21, 2024 | — | Form 144 ↗ |
| Feb 21, 2024 | Todd Alfred Carter Officer | VYGR Voyager Therapeutics, Inc. | 3,365 | $25.1K | — | Feb 21, 2024 | — | Form 144 ↗ |
| Feb 20, 2024 | Todd Alfred Carter Officer | VYGR Voyager Therapeutics, Inc. | 602 | $4,622 | — | Feb 20, 2024 | — | Form 144 ↗ |
| Jan 17, 2024 | Swartz Robin Officer | VYGR Voyager Therapeutics, Inc. | 2,543 | $18.2K | — | Jan 17, 2024 | — | Form 144 ↗ |
| Jan 17, 2024 | Todd Alfred Carter Officer | VYGR Voyager Therapeutics, Inc. | 1,266 | $9,088 | — | Jan 17, 2024 | — | Form 144 ↗ |
| Oct 3, 2023 | Peter P. Pfreundschuh Officer | VYGR Voyager Therapeutics, Inc. | 13,567 | $94.8K | — | Oct 3, 2023 | — | Form 144 ↗ |
| Sep 15, 2023 | Todd Alfred Carter Officer | VYGR Voyager Therapeutics, Inc. | 10,500 | $85.7K | 10b5-1 | Sep 15, 2023 | — | Form 144 ↗ |
| Jul 6, 2023 | Todd Alfred Carter Officer | VYGR Voyager Therapeutics, Inc. | 5,500 | $59.4K | 10b5-1 | Jul 6, 2023 | — | Form 144 ↗ |
| Jun 30, 2023 | Todd Alfred Carter Officer | VYGR Voyager Therapeutics, Inc. | 5,000 | $57.0K | 10b5-1 | Jun 30, 2023 | — | Form 144 ↗ |
42 items, most recent first (up to 50). Every row links to the notice on the SEC's site, and to the Form 4 when we found one. Updated Nov 15, 2026, 8:31 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances